Class IITerminatedD-1399-2019
Drug recall · June 19, 2019
Pentreotide recall
Why: Lack of Processing Controls.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pentreotide (10 uGm), Not for Direct Injection, Synthetopes, Inc.
- Lots / codes
All lots remaining within expiry.
- Quantity
- 20 vials
- Company
- Synthetopes Inc, Conway, SC
- Distribution
- Nationwide.
- Initiated
- May 28, 2019 · Voluntary: Firm initiated
- Classified
- June 20, 2019
- Reported
- June 19, 2019
- Ended
- October 15, 2020
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedJun 19, 2019Sn-DMSA solutionSynthetopes Inc · D-1400-2019Class IITerminatedJun 19, 2019Sn-Mertiatide KitSynthetopes Inc · D-1401-2019Class IITerminatedJun 19, 2019Sulfur Colloid Reaction Vial 1.0 mLSynthetopes Inc · D-1402-2019Class IITerminatedJun 19, 2019Sn-d, l-ExametazimeSynthetopes Inc · D-1403-2019Class IITerminatedJun 19, 2019Sn-DTPA Kit 10 mgSynthetopes Inc · D-1404-2019Class IITerminatedJun 19, 2019Sn-Tetrofosmin Kit 5.0 mLSynthetopes Inc · D-1405-2019Class IITerminatedJun 19, 2019Sn-Pyrophosphate KitSynthetopes Inc · D-1406-2019
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.